Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 312.50 | 120.45 | 422.00 | 568.50 | 0.7423 | 0.7507 |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 312.50 | 120.45 | 490.00 | 568.50 | 0.8619 | 0.8716 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 312.50 | 120.45 | 474.00 | 568.50 | 0.8338 | 0.8440 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 312.50 | 120.45 | 538.00 | 568.50 | 0.9464 | 0.9513 |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 312.50 | 120.45 | 421.00 | 568.50 | 0.7406 | 0.7489 |
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 312.50 | 120.45 | 407.00 | 568.50 | 0.7159 | 0.7227 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 312.50 | 120.45 | 597.00 | 568.50 | 1.0501 | 1.0442 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 643.00 | 568.50 | 1.1310 | 1.1131 | |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 312.50 | 120.45 | 678.00 | 568.50 | 1.1926 | 1.1637 |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 312.50 | 120.45 | 855.00 | 568.50 | 1.5040 | 1.3999 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 740.00 | 568.50 | 1.3017 | 1.2500 | |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 312.50 | 120.45 | 525.00 | 568.50 | 0.9235 | 0.9301 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 312.50 | 120.45 | 651.00 | 568.50 | 1.1451 | 1.1248 |
| MDA-MB-231 | Lapatinib | 10 | uM | 10 | 312.50 | 120.45 | 399.00 | 568.50 | 0.7019 | 0.7075 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 312.50 | 120.45 | 161.00 | 568.50 | 0.2832 | 0.1384 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 312.50 | 120.45 | 442.00 | 568.50 | 0.7775 | 0.7873 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 312.50 | 120.45 | 507.00 | 568.50 | 0.8918 | 0.9003 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 312.50 | 120.45 | 559.00 | 568.50 | 0.9833 | 0.9850 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 312.50 | 120.45 | 482.00 | 568.50 | 0.8479 | 0.8578 |
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 312.50 | 120.45 | 553.00 | 568.50 | 0.9727 | 0.9755 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 411.00 | 568.50 | 0.7230 | 0.7302 | |
| MDA-MB-231 | 0 | uM | 10 | 625.00 | 241.23 | 1022.00 | 1107.50 | 0.9228 | 0.9282 | |
| MDA-MB-231 | 0 | uM | 10 | 625.00 | 241.23 | 1184.00 | 1107.50 | 1.0691 | 1.0617 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 625.00 | 241.23 | 301.00 | 1107.50 | 0.2718 | 0.1059 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 625.00 | 241.23 | 1289.00 | 1107.50 | 1.1639 | 1.1429 |